Balaxi Pharmaceuticals

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue68.9657.7772.6473.6379.69
Expenses68.0756.3871.0372.2377.60
EBITDA2.372.753.193.043.67
Operating Profit1.912.272.632.392.82
Profit Before Tax0.901.381.611.402.09
Net Profit0.290.210.310.611.30
Financial Ratios
Operating Profit Margin3.35%4.89%4.40%4.30%4.55%
Net Profit Margin0.41%0.37%0.43%0.86%1.61%
Earning Per Share (Diluted)0.050.040.060.110.24
Dividends Per Share0.000.000.000.000.00